NCT03612388已完成不适用
Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Isolated CABG Using MiECC (Minimal Extracorporeal Circulation System)
University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 211 人开始时间: 2010年2月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 211
- 试验地点
- 1
- 主要终点
- Change in lab values for cardial biomarkers
研究概览
简要总结
Combined use of a novel cardioplegic formula with MPS® (Myocardial protection system) versus Cardioplexol ® (colloid solution with Procaine, magnesium and potassium) in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •CABG using MPS® or Cardioplexol ®
排除标准
- •use of other colloid solution than Cardioplexol ® or MPS®
- •other inventions than CABG
- •myocardial infarction <7 days before CABG
- •patients denial of data use
结局指标
主要结局
Change in lab values for cardial biomarkers
时间窗: perioperative during hospital stay for CABG
cardial biomarkers measured are high sensitive troponin T (hs-TrT), Creatinkinase, (CK) Creatinkinase myocardial type (CK-MB)
次要结局
- need for intensive care unit(perioperative during hospital stay for CABG)
- bleeding(perioperative during hospital stay for CABG)
- mortality(30 days after CABG)
- dysrhythmia(perioperative during hospital stay for CABG)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABGComplication of Coronary Artery Bypass GraftComplication of Extracorporeal CirculationNCT03609723University Hospital, Basel, Switzerland2,433
已完成
不适用
Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial InfarctionHeart AttackCardioplegia Solution Adverse ReactionCoronary Artery Bypass Grafting (CABG)NCT04309994University Hospital, Basel, Switzerland307
已完成
不适用
Modified Del Nido Versus Custodiol Cardioplegia For Myocardial Protection In Cardiac Surgery.Cardioplegia Solution Adverse ReactionNCT05221294Fayoum University Hospital58
已完成
不适用
Investigation of Myocardial Protection Efficacy of Cardioplegia Solutions Used in Open Heart SurgeryCardiovascular DiseasesMyocardial Reperfusion InjuryNCT06373549Tamer cebe2
招募中
2 期
Comparison of the use of the cardioplegic material through the descending and ascending aorta in organ donatioDonors of organs and tissues.Donors of organs and tissuesIRCT20220919055992N1Iran University of Medical Sciences54